Is NUMIF or MRK a better dividend investment in 2026?

NUMIF currently yields 16666.67% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: NUMIF offers higher current income.

What is the dividend yield difference between NUMIF and MRK?

NUMIF has a forward dividend yield of 16666.67% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 16663.91 percentage points.

Home › Compare › NUMIF vs MRK

NUMIF vs MRK: Dividend Comparison 2026

NUMIF yields 16666.67% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NUMIF wins by $8601297707047409664.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NUMIF

● Live price

16666.67%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8601297707047409664.00M

Annual income

$8,500,961,637,704,150,000,000,000.00

Full NUMIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — NUMIF vs MRK

📍 NUMIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NUMIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NUMIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NUMIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NUMIF

Annual income on $10K today (after 15% tax)

$1,416,666.67/yr

After 10yr DRIP, annual income (after tax)

$7,225,817,392,048,527,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, NUMIF beats the other by $7,225,817,392,048,527,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NUMIF + MRK for your $10,000?

NUMIF: 50%MRK: 50%

100% MRK50/50100% NUMIF

Portfolio after 10yr

$4300648853523704832.00M

Annual income

$4,250,480,818,852,075,000,000,000.00/yr

Blended yield

98.83%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NUMIF

No analyst data

Altman Z

-54.8

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NUMIF buys

MRK buys

No recent congressional trades found for NUMIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNUMIFMRK

Forward yield	16666.67% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$8601297707047409664.00M ✓	$56.8K
Annual income after 10y	$8,500,961,637,704,150,000,000,000.00 ✓	$9,798.13
Total dividends collected	$8594666089931243520.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: NUMIF vs MRK ($10,000, DRIP)

Year	NUMIF Portfolio	NUMIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$1,677,367	$1,666,666.67	$11,206	$366.19	+$1.67M → NUMIF
2	$263,066,849	$261,272,066.46	$12,650	$502.35	+$263.05M → NUMIF
3	$38,576,943,838	$38,295,462,310.00	$14,407	$694.19	+$38576.93M → NUMIF
4	$5,289,656,888,585	$5,248,379,558,677.81	$16,585	$967.82	+$5289656.87M → NUMIF
5	$678,235,585,150,030	$672,575,652,279,244.40	$19,342	$1,363.89	+$678235585.13M → NUMIF
6	$81,321,145,183,775,540	$80,595,433,107,665,010.00	$22,913	$1,947.19	+$81321145183.75M → NUMIF
7	$9,118,299,079,523,715,000	$9,031,285,454,177,076,000.00	$27,662	$2,823.89	+$9118299079523.69M → NUMIF
8	$956,159,646,381,740,000,000	$946,403,066,366,649,700,000.00	$34,159	$4,173.35	+$956159646381740.00M → NUMIF
9	$93,772,027,423,605,150,000,000	$92,748,936,601,976,690,000,000.00	$43,337	$6,308.80	+$93772027423605152.00M → NUMIF
10	$8,601,297,707,047,409,000,000,000	$8,500,961,637,704,150,000,000,000.00	$56,776	$9,798.13	+$8601297707047409664.00M → NUMIF

NUMIF vs MRK: Complete Analysis 2026

NUMIF — Stock

Numinus Wellness Inc. provides solutions to develop and deliver psychedelic-assisted psychotherapy and transform the mental health landscape. The company operates in two divisions, Salvation Botanicals and Numinus Health. The Salvation Botanicals division offers laboratory services, such as cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics; and full suite testing and custom testing of cannabis. The Numinus Health division provides supportive therapies and technologies to heal, connect, and grow with a focus on treating mental health and substance abuse; and services for psychotherapy, counselling, neurofeedback, physiotherapy, and other therapies. This division also offers training, facilities, and other operational resources to practitioners. The company is headquartered in Vancouver, Canada.

Full NUMIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this NUMIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NUMIF vs SCHD NUMIF vs JEPI NUMIF vs O NUMIF vs KO NUMIF vs MAIN NUMIF vs JNJ NUMIF vs ABBV NUMIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.